FGFR signalling in women's cancers

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 12, 2013, Pages 2832-2842

  Fearon, Abbie E ^a   Gould, Charlotte R ^a   Grose, Richard P ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cancer; Fibroblast growth factor (FGF); Fibroblast growth factor receptor (FGFR); Signalling; Therapy

Indexed keywords

1 TERT BUTYL 3 [6 (3,5 DIMETHOXYPHENYL) 2 (4 DIETHYLAMINOBUTYLAMINO)PYRIDO[2,3 D]PYRIMIDIN 7 YL]UREA; AZD 4547; BRIVANIB; CEDIRANIB; DOVITINIB; FIBROBLAST GROWTH FACTOR RECEPTOR; HEPARAN SULFATE; MONOCLONAL ANTIBODY; NINTEDANIB; PONATINIB; PROTEIN TYROSINE KINASE INHIBITOR;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CELL; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CLEAR CELL CARCINOMA; DWARFISM; DYSPLASIA; EMBRYO DEVELOPMENT; ENDOMETRIUM CARCINOMA; GERM LINE; HUMAN; HYPERTENSION; METABOLISM; MUTATION; NEOPLASM; OVARY CANCER; OVARY CARCINOMA; PATHOGENESIS; SURVIVAL; UTERINE CERVIX CARCINOMA;

AUNP; CANCER; CCC; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHROMOGENIC IN SITU HYBRIDISATION; CIN; CISH; CLASSIC LOBULAR CARCINOMA; CLC; CLEAR CELL CARCINOMA; DCIS; DUCTAL CARCINOMA IN SITU; EEC; ENDOMETRIOID ENDOMETRIAL CARCINOMA; ER; FGF; FGFR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR (FGF); FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR); FISH; FLUORESCENCE IN SITU HYBRIDISATION; GENOME WIDE ASSOCIATION STUDY; GOLD NANOPARTICLE; GWAS; HEPARAN SULFATE; HPV; HS; HUMAN PAPILLOMA VIRUS; IDC; IHC; IMMUNOHISTOCHEMISTRY; INVASIVE DUCTAL CARCINOMA; MAB; MICROSATELLITE INSTABILITY; MONOCLONAL ANTIBODY; MSI; NEEC; NON-ENDOMETRIOID ENDOMETRIAL CARCINOMA; OESTROGEN RECEPTOR; PDGFR; PLATELET-DERIVED GROWTH FACTOR RECEPTOR; PR; PROGESTERONE RECEPTOR; RECEPTOR TYROSINE KINASE; RTK; SAETHRE CHOTZEN; SC; SIGNALLING; SMALL NUCLEOTIDES POLYMORPHISM; SNP; THERAPY; TIC; TISSUE MICROARRAY; TKI; TMA; TUMOUR INITIATING CELL; TYROSINE KINASE INHIBITOR; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR;

FEMALE; FIBROBLAST GROWTH FACTORS; GENITAL NEOPLASMS, FEMALE; HUMANS; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84886741007     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.09.017     Document Type: Short Survey

References (150)

1. Z. Ahmed, A.C. Schuller, K. Suhling, C. Tregidgo, and J.E. Ladbury Extracellular point mutations in FGFR2 elicit unexpected changes in intracellular signalling Biochem J 413 2008 37 49 (Pubitemid 351946860)
2. F. Andre, B. Job, P. Dessen, A. Tordai, S. Michiels, and C. Liedtke Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array Clin Cancer Res 15 2009 441 451
3. A. Bai, K. Meetze, N.Y. Vo, S. Kollipara, E.K. Mazsa, and W.M. Winston GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signaling Cancer Res 70 2010 7630 7639
4. J. Bange, D. Prechtl, Y. Cheburkin, K. Specht, N. Harbeck, and M. Schmitt Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele Cancer Res 62 2002 840 847 (Pubitemid 34126962)
5. R.C.J. Bast, B. Hennessy, and G.B. Mills The biology of ovarian cancer: new opportunities for translation 2009
6. E. Bello, G. Colella, V. Scarlato, P. Oliva, A. Berndt, and G. Valbusa E-3810 is a potent dual inhibitor of VEGFR and FGFR that exerts antitumor activity in multiple preclinical models Cancer Res 71 2011 1396 1405
7. A.A. Belov, and M. Mohammadi Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology Cold Spring Harb Perspect Biol 2013 10.1101/cshperspect.a015958 LID - a015958 [pii]
8. A. Bergman, P. Sahlin, M. Emanuelsson, H. Caren, P. Tarnow, and T. Martinsson Germline mutation screening of the Saethre-Chotzen-associated genes TWIST1 and FGFR3 in families with BRCA1/2-negative breast cancer Scand J Plast Reconstr Surg Hand Surg 43 2009 251 255
9. R.T. Bottcher, and C. Niehrs Fibroblast growth factor signaling during early vertebrate development Endocr Rev 26 2005 63 77 (Pubitemid 40209387)
10. U.A. Boyarskikh, N.A. Zarubina, J.A. Biltueva, T.V. Sinkina, E.N. Voronina, and A.F. Lazarev Association of FGFR2 gene polymorphisms with the risk of breast cancer in population of West Siberia Eur J Hum Genet 17 2009 1688 1691
11. E. Brockbank, F. Kokka, A. Bryant, C. Pomel, and K. Reynolds Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer Cochrane Database Syst Rev 3 2013 CD008217
12. A.N. Brooks, E. Kilgour, and P.D. Smith Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer Clin Cancer Res 18 2012 1855 1862
13. A.P. Brown, C.L. Courtney, L.M. King, S.C. Groom, and M.J. Graziano Cartilage dysplasia and tissue mineralization in the rat following administration of a FGF receptor tyrosine kinase inhibitor Toxicol Pathol 33 2005 449 455 (Pubitemid 40995484)
14. E. Brunello, M. Brunelli, G. Bogina, A. Calio, E. Manfrin, and A. Nottegar FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma J Exp Clin Cancer Res 31 2012 103
15. S.A. Byron, M.G. Gartside, C.L. Wellens, P.J. Goodfellow, M.J. Birrer, and I.G. Campbell FGFR2 mutations are rare across histologic subtypes of ovarian cancer Gynecol Oncol 117 2010 125 129
16. S.A. Byron, M.G. Gartside, C.L. Wellens, M.A. Mallon, J.B. Keenan, and M.A. Powell Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation Cancer Res 68 2008 6902 6907
17. S.A. Byron, D.C. Loch, and P.M. Pollock Fibroblast growth factor receptor inhibition synergizes with Paclitaxel and Doxorubicin in endometrial cancer cells Int J Gynaecol Cancer 22 2012 1517 1526
18. Z.W. Cai, Y. Zhang, R.M. Borzilleri, L. Qian, S. Barbosa, and D. Wei Discovery of brivanib alaninate ((S)-((R)-1-(4-(4-fluoro-2-methyl-1H-indol-5- yloxy)-5-methylpyrrolo[2,1-f][1,2,4] triazin-6-yloxy)propan-2-yl)2- aminopropanoate), a novel prodrug of dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinase inhibitor (BMS-540215) 2008
19. L. Catasus, X. Matias-Guiu, P. Machin, J. Munoz, and J. Prat BAX somatic frameshift mutations in endometrioid adenocarcinomas of the endometrium: evidence for a tumor progression role in endometrial carcinomas with microsatellite instability Lab Invest 78 1998 1439 1444 (Pubitemid 28546087)
20. U. Cavallaro, J. Niedermeyer, M. Fuxa, and G. Christofori N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling Nat Cell Biol 3 2001 650 657 (Pubitemid 32624421)
21. J.P. Cerliani, S.I. Vanzulli, C.P. Pinero, M.C. Bottino, A. Sahores, and M. Nunez Associated expressions of FGFR-2 and FGFR-3: from mouse mammary gland physiology to human breast cancer Breast Cancer Res Treat 133 2012 997 1008
22. F. Chen, M. Lv, Y. Xue, J. Zhou, F. Hu, and X. Chen Genetic variants of fibroblast growth factor receptor 2 (FGFR2) are associated with breast cancer risk in Chinese women of the Han nationality Immunogenetics 64 2012 71 76
23. A.M. Chioni, and R. Grose FGFR1 cleavage and nuclear translocation regulates breast cancer cell behavior J Cell Biol 197 2012 801 817
24. E.Y. Cho, Y. Choi, S.W. Chae, J.H. Sohn, and G.H. Ahn Immunohistochemical study of the expression of adhesion molecules in ovarian serous neoplasms Pathol Int 56 2006 62 70
25. V. Chopra, T.V. Dinh, and E.V. Hannigan Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer Cancer Invest 16 1998 152 159 (Pubitemid 28158437)
26. C. Christensen, J.B. Lauridsen, V. Berezin, E. Bock, and V.V. Kiselyov The neural cell adhesion molecule binds to fibroblast growth factor receptor 2 FEBS Lett 580 2006 3386 3390 (Pubitemid 43795917)
27. C. Cole, S. Lau, A. Backen, A. Clamp, G. Rushton, and C. Dive Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer Cancer Biol Ther 10 2010 495 504
28. N. Colombo, and U. Cavallaro The interplay between NCAM and FGFR signalling underlies ovarian cancer progression Ecancermedicalscience 5 2011 226
29. Consortium Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 Nat Genet 26 2000 345 348
30. J.E. Cortes, H. Kantarjian, N.P. Shah, D. Bixby, M.J. Mauro, and I. Flinn Ponatinib in refractory Philadelphia chromosome-positive leukemias N Engl J Med 367 2012 2075 2088
31. S.R. Coughlin, P.J. Barr, L.S. Cousens, L.J. Fretto, and L.T. Williams Acidic and basic fibroblast growth factors stimulate tyrosine kinase activity in vivo J Biol Chem 263 1988 988 993 (Pubitemid 18044732)
32. J.E. Darnell Jr. STATs and gene regulation Science 277 1997 1630 1635 (Pubitemid 27446219)
33. L. De Cecco, L. Marchionni, M. Gariboldi, J.F. Reid, M.S. Lagonigro, and S. Caramuta Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2 Oncogene 23 2004 8171 8183 (Pubitemid 39531858)
34. C.R. Degnin, M.B. Laederich, and W.A. Horton Ligand activation leads to regulated intramembrane proteolysis of fibroblast growth factor receptor 3 Mol Biol Cell 22 2011 3861 3873
35. K. Dorey, and E. Amaya FGF signalling: diverse roles during early vertebrate embryogenesis Development 137 2010 3731 3742
36. J. Dubrulle, and O. Pourquie fgf8 mRNA decay establishes a gradient that couples axial elongation to patterning in the vertebrate embryo Nature 427 2004 419 422 (Pubitemid 38168489)
37. B.D. Duggan, J.C. Felix, L.I. Muderspach, D. Tourgeman, J. Zheng, and D. Shibata Microsatellite instability in sporadic endometrial carcinoma J Natl Cancer Inst 86 1994 1216 1221 (Pubitemid 24253696)
38. A. Dutt, H.B. Salvesen, T.H. Chen, A.H. Ramos, R.C. Onofrio, and C. Hatton Drug-sensitive FGFR2 mutations in endometrial carcinoma Proc Natl Acad Sci USA 105 2008 8713 8717 (Pubitemid 351987745)
39. D.F. Easton, K.A. Pooley, A.M. Dunning, P.D. Pharoah, D. Thompson, and D.G. Ballinger Genome-wide association study identifies novel breast cancer susceptibility loci Nature 447 2007 1087 1093 (Pubitemid 47014426)
40. S. Elbauomy Elsheikh, A.R. Green, M.B. Lambros, N.C. Turner, M.J. Grainge, and D. Powe FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis Breast Cancer Res 9 2007 R23
41. D. Fanale, V. Amodeo, L.R. Corsini, S. Rizzo, V. Bazan, and A. Russo Breast cancer genome-wide association studies: there is strength in numbers Oncogene 31 2012 2121 2128
42. B. Feldman, W. Poueymirou, V.E. Papaioannou, T.M. DeChiara, and M. Goldfarb Requirement of FGF-4 for postimplantation mouse development Science. 267 1995 246 249
43. J. Fujimoto, S. Ichigo, M. Hori, R. Hirose, H. Sakaguchi, and T. Tamaya Expression of basic fibroblast growth factor and its mRNA in advanced uterine cervical cancers Cancer Lett 111 1997 21 26 (Pubitemid 27068214)
44. C.M. Furdui, E.D. Lew, J. Schlessinger, and K.S. Anderson Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction Mol Cell 21 2006 711 717 (Pubitemid 43290737)
45. P.R. Gavine, L. Mooney, E. Kilgour, A.P. Thomas, K. Al-Kadhimi, and S. Beck AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family Cancer Res 72 2012 2045 2056
46. V. Gelsi-Boyer, B. Orsetti, N. Cervera, P. Finetti, F. Sircoulomb, and C. Rouge Comprehensive profiling of 8p11-12 amplification in breast cancer Mol Cancer Res 3 2005 655 667 (Pubitemid 43042995)
47. A. Ghabrial, S. Luschnig, M.M. Metzstein, and M.A. Krasnow Branching morphogenesis of the Drosophila tracheal system Annu Rev Cell Dev Biol 19 2003 623 647 (Pubitemid 37487363)
48. M. Glenisson, S. Vacher, C. Callens, A. Susini, G. Cizeron-Clairac, and R. Le Scodan Identification of new candidate therapeutic target genes in triple-negative breast cancer Genes Cancer 3 2012 63 70
49. K.L. Gorringe, S. Jacobs, E.R. Thompson, A. Sridhar, W. Qiu, and D.Y. Choong High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications Clin Cancer Res 13 2007 4731 4739 (Pubitemid 47294779)
50. N. Gotoh Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins Cancer Sci 99 2008 1319 1325 (Pubitemid 351761719)
51. J.M. Gozgit, R.M. Squillace, M.J. Wongchenko, D. Miller, S. Wardwell, and Q. Mohemmad Combined targeting of FGFR2 and mTOR by ponatinib and ridaforolimus results in synergistic antitumor activity in FGFR2 mutant endometrial cancer models Cancer Chemother Pharmacol 71 2013 1315 1323
52. J.M. Gozgit, M.J. Wong, L. Moran, S. Wardwell, Q.K. Mohemmad, and N.I. Narasimhan Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models Mol Cancer Ther 11 2012 690 699
53. H. Greulich, and P.M. Pollock Targeting mutant fibroblast growth factor receptors in cancer Trends Mol Med 17 2011 283 292
54. V. Guagnano, A. Kauffmann, S. Wohrle, C. Stamm, M. Ito, and L. Barys FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a selective pan-FGFR inhibitor Cancer Discov 2 2012 1118 1133
55. N. Hacohen, S. Kramer, D. Sutherland, Y. Hiromi, and M.A. Krasnow sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways Cell 92 1998 253 263 (Pubitemid 28073048)
56. T. Hagemann, T. Bozanovic, S. Hooper, A. Ljubic, V.I. Slettenaar, and J.L. Wilson Molecular profiling of cervical cancer progression Br J Cancer 96 2007 321 328 (Pubitemid 46160638)
57. T.C. Harding, L. Long, S. Palencia, H. Zhang, A. Sadra, and K. Hestir Blockade of nonhormonal fibroblast growth factors by FP-1039 inhibits growth of multiple types of cancer Sci Transl Med 5 2013 178ra39
58. P. Huang, and M.J. Stern FGF signaling in flies and worms: more and more relevant to vertebrate biology Cytokine Growth Factor Rev 16 2005 151 158 (Pubitemid 40616113)
59. P.E. Huijts, M. van Dongen, M.C. de Goeij, A.J. van Moolenbroek, F. Blanken, and M.P. Vreeswijk Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10 Breast Cancer Res 13 2011 R72
60. D.J. Hunter, P. Kraft, K.B. Jacobs, D.G. Cox, M. Yeager, and S.E. Hankinson A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer Nat Genet 39 2013 870 874
61. A. Issa, J.W. Gill, M.R. Heideman, O. Sahin, S. Wiemann, and J.H. Dey Combinatorial targeting of FGF and ErbB receptors blocks growth and metastatic spread of breast cancer models Breast Cancer Res 15 2013 R8
62. J. Jacquemier, J. Adelaide, P. Parc, F. Penault-Llorca, J. Planche, and O. deLapeyriere Expression of the FGFR1 gene in human breast-carcinoma cells Int J Cancer 59 1994 373 378 (Pubitemid 24331829)
63. S. Jain, D.G. Hirst, and J.M. O'Sullivan Gold nanoparticles as novel agents for cancer therapy Br J Radiol 85 2012 101 113
64. V.K. Jain, and N.C. Turner Challenges and opportunities in the targeting of fibroblast growth factor receptors in breast cancer Breast Cancer Res 14 2012 208
65. M.H. Jang, E.J. Kim, Y. Choi, H.E. Lee, Y.J. Kim, and J.H. Kim FGFR1 is amplified during the progression of in situ to invasive breast carcinoma Breast Cancer Res 14 2012 R115
66. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
67. D.E. Johnson, and L.T. Williams Structural and functional diversity in the FGF receptor multigene family Adv Cancer Res 60 1993 1 41
68. J. Kalinina, K. Dutta, D. Ilghari, A. Beenken, R. Goetz, and A.V. Eliseenkova The alternatively spliced acid box region plays a key role in FGF receptor autoinhibition Structure 20 2012 77 88
69. R. Kawase, T. Ishiwata, Y. Matsuda, M. Onda, M. Kudo, and T. Takeshita Expression of fibroblast growth factor receptor 2 IIIc in human uterine cervical intraepithelial neoplasia and cervical cancer Int J Oncol 36 2010 331 340
70. S.W. Kim, A. Dubrovska, R.J. Salamone, J.R. Walker, K.B. Grandinetti, and G.M. Bonamy FGFR2 promotes breast tumorigenicity through maintenance of breast tumor-initiating cells PLoS One 8 2013 e51671
71. V. Knights, and S.J. Cook De-regulated FGF receptors as therapeutic targets in cancer Pharmacol Ther 125 2010 105 117
72. G.E. Konecny, T. Kolarova, N.A. O'Brien, B. Winterhoff, G. Yang, and J. Qi Activity of the fibroblast growth factor receptor inhibitors dovitinib (TKI258) and NVP-BGJ398 in human endometrial cancer cells Mol Cancer Ther 12 2013 632 642
73. D. Kovalenko, X. Yang, R.J. Nadeau, L.K. Harkins, and R. Friesel Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK activation J Biol Chem 278 2003 14087 14091 (Pubitemid 36799955)
74. G. Kurban, T. Ishiwata, M. Kudo, M. Yokoyama, Y. Sugisaki, and Z. Naito Expression of keratinocyte growth factor receptor (KGFR/FGFR2 IIIb) in human uterine cervical cancer Oncol Rep 11 2004 987 991
75. K. Kuroso, Y. Imai, M. Kobayashi, K. Yanagimoto, T. Suzuki, and M. Kojima Immunohistochemical detection of fibroblast growth factor receptor 3 in human breast cancer: correlation with clinicopathological/molecular parameters and prognosis Pathobiology 77 2010 231 240
76. G. Liang, Z. Liu, J. Wu, Y. Cai, and X. Li Anticancer molecules targeting fibroblast growth factor receptors Trends Pharmacol Sci 33 2012 531 541
77. D. Lister-Sharp, M.S. McDonagh, K.S. Khan, and J. Kleijnen A rapid and systematic review of the effectiveness and cost-effectiveness of the taxanes used in the treatment of advanced breast and ovarian cancer Health Technol Assess 4 2000 1 113
78. J. Long, X.O. Shu, Q. Cai, Y.T. Gao, Y. Zheng, and G. Li Evaluation of breast cancer susceptibility loci in Chinese women Cancer Epidemiol Biomarkers Prev 19 2010 2357 2365
79. J. Matsui, Y. Yamamoto, Y. Funahashi, A. Tsuruoka, T. Watanabe, and T. Wakabayashi E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition Int J Cancer 122 2008 664 671 (Pubitemid 350308963)
80. W.P. McGuire, and M. Markman Primary ovarian cancer chemotherapy: current standards of care Br J Cancer 89 Suppl 3 2003 S3 S8
81. K.B. Meyer, A.T. Maia, M. O'Reilly, A.E. Teschendorff, S.F. Chin, and C. Caldas Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer PLoS Biol 6 2008 e108
82. M. Mohammadi, C.A. Dionne, W. Li, N. Li, T. Spivak, and A.M. Honegger Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis Nature 358 1992 681 684
83. M. Mohammadi, S. Froum, J.M. Hamby, M.C. Schroeder, R.L. Panek, and G.H. Lu Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain Embo J 17 1998 5896 5904 (Pubitemid 28474784)
84. M. Mohammadi, G. McMahon, L. Sun, C. Tang, P. Hirth, and B.K. Yeh Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors Science 276 1997 955 960 (Pubitemid 27209095)
85. M. Mohammadi, J. Schlessinger, and S.R. Hubbard Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism 1996
86. M.C. Naski, Q. Wang, J. Xu, and D.M. Ornitz Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia Nature Genet 13 1996 233 237 (Pubitemid 26166160)
87. G. Noronha, J. Cao, C.P. Chow, E. Dneprovskaia, R.M. Fine, and J. Hood Inhibitors of ABL and the ABL-T315I mutation Curr Top Med Chem 8 2008 905 921 (Pubitemid 351984712)
88. J.C. Obel, G. Friberg, and G.F. Fleming Chemotherapy in endometrial cancer Clin Adv Hematol Oncol 4 2006 459 468 (Pubitemid 44018491)
89. S.K. Olsen, O.A. Ibrahimi, A. Raucci, F. Zhang, A.V. Eliseenkova, and A. Yayon Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity Proc Natl Acad Sci USA 101 2004 935 940 (Pubitemid 38160562)
90. D.M. Ornitz, and N. Itoh Fibroblast growth factors Genome Biol. 2 2001 REVIEWS3005
91. D.M. Ornitz, J. Xu, J.S. Colvin, D.G. McEwen, C.A. MacArthur, and F. Coulier Receptor specificity of the fibroblast growth factor family J Biol Chem 271 1996 15292 15297 (Pubitemid 26195013)
92. A. Orr-Urtreger, M.T. Bedford, T. Burakova, E. Arman, Y. Zimmer, and A. Yayon Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2) 1993
93. A. Patel, A.K. Tiwari, E.E. Chufan, K. Sodani, N. Anreddy, and S. Singh PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells Cancer Chemother Pharmacol 72 2013 189 199
94. C.M. Perou, T. Sorlie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, and C.A. Rees Molecular portraits of human breast tumours Nature 406 2000 747 752
95. M.J. Piccart-Gebhart, M. Procter, B. Leyland-Jones, A. Goldhirsch, M. Untch, and I. Smith Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer N Engl J Med 2005 1659 1672 (Pubitemid 41464705)
96. A.N. Plotnikov, J. Schlessinger, S.R. Hubbard, and M. Mohammadi Structural basis for FGF receptor dimerization and activation Cell 98 1999 641 650 (Pubitemid 29418955)
97. U.M. Polanska, D.G. Fernig, and T. Kinnunen Extracellular interactome of the FGF receptor-ligand system: complexities and the relative simplicity of the worm Dev Dyn 238 2009 277 293
98. P.M. Pollock, M.G. Gartside, L.C. Dejeza, M.A. Powell, M.A. Mallon, and H. Davies Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes Oncogene 26 2007 7158 7162 (Pubitemid 350059681)
99. J. Qing, X. Du, Y. Chen, P. Chan, H. Li, and P. Wu Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice J Clin Invest 2009
100. L. Raskin, M. Pinchev, C. Arad, F. Lejbkowicz, A. Tamir, and H.S. Rennert FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations Cancer Epidemiol Biomarkers Prev 17 2008 1060 1065
101. J.S. Reis-Filho, P.T. Simpson, N.C. Turner, M.B. Lambros, C. Jones, and A. Mackay FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas Clin Cancer Res 12 2006 6652 6662 (Pubitemid 44876833)
102. E.S. Rinella, Y. Shao, L. Yackowski, S. Pramanik, R. Oratz, and F. Schnabel Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation Hum Genet 132 2013 523 536
103. J.I. Risinger, A. Berchuck, M.F. Kohler, P. Watson, H.T. Lynch, and J. Boyd Genetic instability of microsatellites in endometrial carcinoma Cancer Res 53 1993 5100 5103 (Pubitemid 23333372)
104. E.S. Robinson, E.V. Khankin, S.A. Karumanchi, and B.D. Humphreys Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker Semin Nephrol 30 2010 591 601
105. P. Sahlin, P. Tarnow, T. Martinsson, and G. Stenman Germline mutation in the FGFR3 gene in a TWIST1-negative family with Saethre-Chotzen syndrome and breast cancer Genes Chromosomes Cancer 48 2009 285 288
106. J. Schlessinger, A.N. Plotnikov, O.A. Ibrahimi, A.V. Eliseenkova, B.K. Yeh, and A. Yayon Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization Mol Cell 6 2000 743 750
107. S.J. Schnitt Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy Mod Pathol 23 Suppl 2 2010 S60 S66
108. N. Seitzer, T. Mayr, S. Streit, and A. Ullrich A single nucleotide change in the mouse genome accelerates breast cancer progression Cancer Res 70 2010 802 812
109. K. Song, P. Xu, Y. Meng, F. Geng, J. Li, and Z. Li Smart gold nanoparticles enhance killing effect on cancer cells Int J Oncol 42 2013 597 608
110. C.R. Stadler, P. Knyazev, J. Bange, and A. Ullrich FGFR4 GLY388 isotype suppresses motility of MDA-MB-231 breast cancer cells by EDG-2 gene repression Cellular Signal 18 2006 783 794 (Pubitemid 43208932)
111. D.J. Stauber, A.D. DiGabriele, and W.A. Hendrickson Structural interactions of fibroblast growth factor receptor with its ligands Proc Natl Acad Sci USA 97 2000 49 54 (Pubitemid 30055782)
112. I.A. Steele, R.J. Edmondson, J.N. Bulmer, B.S. Bolger, H.Y. Leung, and B.R. Davies Induction of FGF receptor 2-IIIb expression and response to its ligands in epithelial ovarian cancer Oncogene 20 2001 5878 5887 (Pubitemid 32937957)
113. I.A. Steele, R.J. Edmondson, H.Y. Leung, and B.R. Davies Ligands to FGF receptor 2-IIIb induce proliferation, motility, protection from cell death and cytoskeletal rearrangements in epithelial ovarian cancer cell lines Growth Factors 24 2006 45 53 (Pubitemid 43108775)
114. H.D. Sun, M. Malabunga, J.R. Tonra, R. DiRenzo, F.E. Carrick, and H. Zheng Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys Am J Physiol Endocrinol Metab. 292 2007 E964 E976
115. S. Sun, Y. Jiang, G. Zhang, H. Song, X. Zhang, and Y. Zhang Increased expression of fibroblastic growth factor receptor 2 is correlated with poor prognosis in patients with breast cancer J Surg Oncol 105 2012 773 779
116. X. Sun, E.N. Meyers, M. Lewandoski, and G.R. Martin Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo Genes Dev 13 1999 1834 1846 (Pubitemid 29353050)
117. A. Szlachcic, K. Pala, M. Zakrzewska, P. Jakimowicz, A. Wiedlocha, and J. Otlewski FGF1-gold nanoparticle conjugates targeting FGFR efficiently decrease cell viability upon NIR irradiation Int J Nanomedicine 7 2012 5915 5927
118. M. Takano, Y. Kikuchi, N. Yaegashi, K. Kuzuya, M. Ueki, and H. Tsuda Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging 2006
119. F. Taniguchi, H. Itamochi, T. Harada, and N. Terakawa Fibroblast growth factor receptor 2 expression may be involved in transformation of ovarian endometrioma to clear cell carcinoma of the ovary Int J Gynaecol Cancer 23 2013 791 796
120. S.M. Temkin, and G. Fleming Current treatment of metastatic endometrial cancer Cancer Control 16 2009 38 45
121. C. Theillet, J. Adelaide, G. Louason, F. Bonnet-Dorion, J. Jacquemier, and J. Adnane FGFRI and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers 1993
122. C. Thussbas, J. Nahrig, S. Streit, J. Bange, M. Kriner, and R. Kates FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer J Clin Oncol 24 2006 3747 3755 (Pubitemid 46622313)
123. D.C. Tomlinson, M.A. Knowles, and V. Speirs Mechanisms of FGFR3 actions in endocrine resistant breast cancer 2011
124. S. Torii, M. Kusakabe, T. Yamamoto, M. Maekawa, and E. Nishida Sef is a spatial regulator for Ras/MAP kinase signaling Dev Cell 7 2004 33 44 (Pubitemid 39172686)
125. S. Trudel, Z.H. Li, E. Wei, M. Wiesmann, H. Chang, and C. Chen CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma Blood 105 2005 2941 2948 (Pubitemid 40446289)
126. S. Trudel, A.K. Stewart, E. Rom, E. Wei, Z.H. Li, and S. Kotzer The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells Blood 107 2006 4039 4046 (Pubitemid 43726812)
127. N. Turner, and R. Grose Fibroblast growth factor signalling: from development to cancer Nat Rev Cancer 10 2010 116 129
128. N. Turner, M.B. Lambros, H.M. Horlings, A. Pearson, R. Sharpe, and R. Natrajan Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets Oncogene 29 2010 2013 2023
129. N. Turner, A. Pearson, R. Sharpe, M. Lambros, F. Geyer, and M.A. Lopez-Garcia FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer Cancer Res 70 2010 2085 2094
130. S. Vainikka, J. Partanen, P. Bellosta, F. Coulier, D. Birnbaum, and C. Basilico Fibroblast growth factor receptor-4 shows novel features in genomic structure, ligand binding and signal transduction Embo J 11 1992 4273 4280
131. E. Valve, P. Martikainen, J. Seppanen, S. Oksjoki, S. Hinkka, and L. Anttila Expression of fibroblast growth factor (FGF)-8 isoforms and FGF receptors in human ovarian tumors Int J Cancer 88 2000 718 725
132. B.W. van Rhijn, A.A. van Tilborg, L. Lurkin, J. Bonaventure, A. de Vries, and J.P. Thiery Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders 2002
133. T. Wakioka, A. Sasaki, R. Kato, T. Shouda, A. Matsumoto, and K. Miyoshi Spred is a Sprouty-related suppressor of Ras signalling Nature 412 2001 647 651 (Pubitemid 32772277)
134. K. Walker, and M. Padhiar AACR-NCI-EORTC - 21st International Symposium. Molecular Targets and Cancer Therapeutics - Part 2 IDrugs 13 2010 10 12
135. L. Wang, W.A. Rudert, I. Loutaev, V. Roginskaya, and S.J. Corey Repression of c-Cbl leads to enhanced G-CSF Jak-STAT signaling without increased cell proliferation Oncogene 21 2002 5346 5355 (Pubitemid 34948145)
136. J. Wesche, K. Haglund, and E.M. Haugsten Fibroblast growth factors and their receptors in cancer Biochem J 437 2011 199 213
137. L.M. Wheldon, N. Khodabukus, S.J. Patey, T.G. Smith, J.K. Heath, and M.K. Hajihosseini Identification and characterization of an inhibitory fibroblast growth factor receptor 2 (FGFR2) molecule, up-regulated in an Apert Syndrome mouse model Biochem J 436 2011 71 81
138. A.O. Wilkie Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations Cytokine Growth Factor Rev 16 2005 187 203 (Pubitemid 40616116)
139. A.O. Wilkie, S.J. Patey, S.H. Kan, A.M. van den Ouweland, and B.C. Hamel FGFs, their receptors, and human limb malformations: clinical and molecular correlations Am J Med Genet 112 2002 266 278
140. S.N. Wingo, T.D. Gallardo, E.A. Akbay, M.C. Liang, C.M. Contreras, and T. Boren Somatic LKB1 mutations promote cervical cancer progression PLoS One 4 2009 e5137
141. S. Wohrle, O. Bonny, N. Beluch, S. Gaulis, C. Stamm, and M. Scheibler FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone J Bone Miner Res 2011
142. W. Xian, L. Pappas, D. Pandya, L.M. Selfors, P.W. Derksen, and M. de Bruin Fibroblast growth factor receptor 1-transformed mammary epithelial cells are dependent on RSK activity for growth and survival Cancer Res 69 2009 2244 2251
143. G. Yan, Y. Fukabori, G. McBride, S. Nikolaropolous, and W.L. McKeehan Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy Mol Cell Biol 13 1993 4513 4522 (Pubitemid 23220358)
144. R.B. Yang, C.K. Ng, S.M. Wasserman, L.G. Komuves, M.E. Gerritsen, and J.N. Topper A novel interleukin-17 receptor-like protein identified in human umbilical vein endothelial cells antagonizes basic fibroblast growth factor-induced signaling J Biol Chem 278 2003 33232 33238 (Pubitemid 37055772)
145. A. Yayon, M. Klagsbrun, J.D. Esko, P. Leder, and D.M. Ornitz Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor Cell 64 1991 841 848 (Pubitemid 121001170)
146. A. Yeramian, G. Moreno-Bueno, X. Dolcet, L. Catasus, M. Abal, and E. Colas Endometrial carcinoma: molecular alterations involved in tumor development and progression Oncogene 32 2013 403 413
147. S. Zecchini, L. Bombardelli, A. Decio, M. Bianchi, G. Mazzarol, and F. Sanguineti The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling Embo Mol Med 3 2011 480 494
148. G. Zhao, W.Y. Li, D. Chen, J.R. Henry, H.Y. Li, and Z. Chen A novel, selective inhibitor of fibroblast growth factor receptors that shows a potent broad spectrum of antitumor activity in several tumor xenograft models Mol Cancer Ther 10 2011 2200 2210
149. B.B. Zhou, H. Zhang, M. Damelin, K.G. Geles, J.C. Grindley, and P.B. Dirks Tumour-initiating cells: challenges and opportunities for anticancer drug discovery Nat Rev Drug Dis 8 2009 806 823
150. X. Zhu, L. Zheng, S.L. Asa, and S. Ezzat Loss of heterozygosity and DNA methylation affect germline fibroblast growth factor receptor 4 polymorphism to direct allelic selection in breast cancer Am J Pathol 177 2010 2860 2869